Simultaneous CD8<sup>+</sup> T-Cell Immune Response against SARS-Cov-2 S, M, and N Induced by Endogenously Engineered Extracellular Vesicles in Both Spleen and Lungs

Most advanced vaccines against severe acute respiratory syndrome coronavirus (SARS-CoV)-2 are designed to induce antibodies against spike (S) protein. Differently, we developed an original strategy to induce CD8<sup>+</sup> T cytotoxic lymphocyte (CTL) immunity based on in vivo engineeri...

Full description

Bibliographic Details
Main Authors: Flavia Ferrantelli, Chiara Chiozzini, Francesco Manfredi, Andrea Giovannelli, Patrizia Leone, Maurizio Federico
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/9/3/240
_version_ 1797541911046651904
author Flavia Ferrantelli
Chiara Chiozzini
Francesco Manfredi
Andrea Giovannelli
Patrizia Leone
Maurizio Federico
author_facet Flavia Ferrantelli
Chiara Chiozzini
Francesco Manfredi
Andrea Giovannelli
Patrizia Leone
Maurizio Federico
author_sort Flavia Ferrantelli
collection DOAJ
description Most advanced vaccines against severe acute respiratory syndrome coronavirus (SARS-CoV)-2 are designed to induce antibodies against spike (S) protein. Differently, we developed an original strategy to induce CD8<sup>+</sup> T cytotoxic lymphocyte (CTL) immunity based on in vivo engineering of extracellular vesicles (EVs). This is a new vaccination approach based on intramuscular injection of DNA expression vectors coding for a biologically inactive HIV-1 Nef protein (Nef<sup>mut</sup>) with an unusually high efficiency of incorporation into EVs, even when foreign polypeptides are fused to its C-terminus. Nanovesicles containing Nef<sup>mut</sup>-fused antigens released by muscle cells can freely circulate into the body and are internalized by antigen-presenting cells. Therefore, EV-associated antigens can be cross-presented to prime antigen-specific CD8<sup>+</sup> T-cells. To apply this technology to a strategy of anti-SARS-CoV-2 vaccine, we designed DNA vectors expressing the products of fusion between Nef<sup>mut</sup> and different viral antigens, namely N- and C-terminal moieties of S (referred to as S1 and S2), M, and N. We provided evidence that all fusion products are efficiently uploaded in EVs. When the respective DNA vectors were injected in mice, a strong antigen-specific CD8<sup>+</sup> T cell immunity became detectable in spleens and, most important, in lung airways. Co-injection of DNA vectors expressing the diverse SARS-CoV-2 antigens resulted in additive immune responses in both spleen and lungs. Hence, DNA vectors expressing Nef<sup>mut</sup>-based fusion proteins can be proposed for new anti-SARS-CoV-2 vaccine strategies.
first_indexed 2024-03-10T13:23:14Z
format Article
id doaj.art-72125878bdb04ff2b5ec0ad58334154f
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-03-10T13:23:14Z
publishDate 2021-03-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-72125878bdb04ff2b5ec0ad58334154f2023-11-21T09:52:44ZengMDPI AGVaccines2076-393X2021-03-019324010.3390/vaccines9030240Simultaneous CD8<sup>+</sup> T-Cell Immune Response against SARS-Cov-2 S, M, and N Induced by Endogenously Engineered Extracellular Vesicles in Both Spleen and LungsFlavia Ferrantelli0Chiara Chiozzini1Francesco Manfredi2Andrea Giovannelli3Patrizia Leone4Maurizio Federico5National Center for Global Health, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, ItalyNational Center for Global Health, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, ItalyNational Center for Global Health, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, ItalyNational Center for Animal Experimentation and Welfare, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, ItalyNational Center for Global Health, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, ItalyNational Center for Global Health, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, ItalyMost advanced vaccines against severe acute respiratory syndrome coronavirus (SARS-CoV)-2 are designed to induce antibodies against spike (S) protein. Differently, we developed an original strategy to induce CD8<sup>+</sup> T cytotoxic lymphocyte (CTL) immunity based on in vivo engineering of extracellular vesicles (EVs). This is a new vaccination approach based on intramuscular injection of DNA expression vectors coding for a biologically inactive HIV-1 Nef protein (Nef<sup>mut</sup>) with an unusually high efficiency of incorporation into EVs, even when foreign polypeptides are fused to its C-terminus. Nanovesicles containing Nef<sup>mut</sup>-fused antigens released by muscle cells can freely circulate into the body and are internalized by antigen-presenting cells. Therefore, EV-associated antigens can be cross-presented to prime antigen-specific CD8<sup>+</sup> T-cells. To apply this technology to a strategy of anti-SARS-CoV-2 vaccine, we designed DNA vectors expressing the products of fusion between Nef<sup>mut</sup> and different viral antigens, namely N- and C-terminal moieties of S (referred to as S1 and S2), M, and N. We provided evidence that all fusion products are efficiently uploaded in EVs. When the respective DNA vectors were injected in mice, a strong antigen-specific CD8<sup>+</sup> T cell immunity became detectable in spleens and, most important, in lung airways. Co-injection of DNA vectors expressing the diverse SARS-CoV-2 antigens resulted in additive immune responses in both spleen and lungs. Hence, DNA vectors expressing Nef<sup>mut</sup>-based fusion proteins can be proposed for new anti-SARS-CoV-2 vaccine strategies.https://www.mdpi.com/2076-393X/9/3/240SARS-CoV-2extracellular vesiclesCD8<sup>+</sup> T cell immunityNef
spellingShingle Flavia Ferrantelli
Chiara Chiozzini
Francesco Manfredi
Andrea Giovannelli
Patrizia Leone
Maurizio Federico
Simultaneous CD8<sup>+</sup> T-Cell Immune Response against SARS-Cov-2 S, M, and N Induced by Endogenously Engineered Extracellular Vesicles in Both Spleen and Lungs
Vaccines
SARS-CoV-2
extracellular vesicles
CD8<sup>+</sup> T cell immunity
Nef
title Simultaneous CD8<sup>+</sup> T-Cell Immune Response against SARS-Cov-2 S, M, and N Induced by Endogenously Engineered Extracellular Vesicles in Both Spleen and Lungs
title_full Simultaneous CD8<sup>+</sup> T-Cell Immune Response against SARS-Cov-2 S, M, and N Induced by Endogenously Engineered Extracellular Vesicles in Both Spleen and Lungs
title_fullStr Simultaneous CD8<sup>+</sup> T-Cell Immune Response against SARS-Cov-2 S, M, and N Induced by Endogenously Engineered Extracellular Vesicles in Both Spleen and Lungs
title_full_unstemmed Simultaneous CD8<sup>+</sup> T-Cell Immune Response against SARS-Cov-2 S, M, and N Induced by Endogenously Engineered Extracellular Vesicles in Both Spleen and Lungs
title_short Simultaneous CD8<sup>+</sup> T-Cell Immune Response against SARS-Cov-2 S, M, and N Induced by Endogenously Engineered Extracellular Vesicles in Both Spleen and Lungs
title_sort simultaneous cd8 sup sup t cell immune response against sars cov 2 s m and n induced by endogenously engineered extracellular vesicles in both spleen and lungs
topic SARS-CoV-2
extracellular vesicles
CD8<sup>+</sup> T cell immunity
Nef
url https://www.mdpi.com/2076-393X/9/3/240
work_keys_str_mv AT flaviaferrantelli simultaneouscd8supsuptcellimmuneresponseagainstsarscov2smandninducedbyendogenouslyengineeredextracellularvesiclesinbothspleenandlungs
AT chiarachiozzini simultaneouscd8supsuptcellimmuneresponseagainstsarscov2smandninducedbyendogenouslyengineeredextracellularvesiclesinbothspleenandlungs
AT francescomanfredi simultaneouscd8supsuptcellimmuneresponseagainstsarscov2smandninducedbyendogenouslyengineeredextracellularvesiclesinbothspleenandlungs
AT andreagiovannelli simultaneouscd8supsuptcellimmuneresponseagainstsarscov2smandninducedbyendogenouslyengineeredextracellularvesiclesinbothspleenandlungs
AT patrizialeone simultaneouscd8supsuptcellimmuneresponseagainstsarscov2smandninducedbyendogenouslyengineeredextracellularvesiclesinbothspleenandlungs
AT mauriziofederico simultaneouscd8supsuptcellimmuneresponseagainstsarscov2smandninducedbyendogenouslyengineeredextracellularvesiclesinbothspleenandlungs